Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference135 articles.
1. Synowiec A, Szcsepanski A, Barreto-Duran E, Lie LK, Pyrc K. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Microbiol Rev. 2021;34:e00133-e220.
2. Batiha GES, Al-kuraishy HM, Al-Gareeb AI, Alruwaili M, AlRuwaili R, Albogami SM, et al. Targeting of neuroinflammation by glibenclamide in Covid-19: old weapon from arsenal. Inflammopharmacology. 2022;31:1.
3. Elfaki I. The impact of the coronavirus (COVID-19) infection on the drug-metabolizing enzymes cytochrome P450s. Drug Metab Bioanal Lett. 2022;15:71–4.
4. WHO. Tracking SARS-CoV-2 variants [Internet]. World Heal. Organ. 2023. p. 1–14. Available from: https://www.who.int/activities/tracking-SARS-CoV-2-variants. Accessed 9 Feb 2023.
5. Di Lorenzo G, Di Trolio R, Kozlakidis Z, Busto G, Ingenito C, Buonerba L, et al. COVID 19 therapies and anti-cancer drugs: a systematic review of recent literature. Crit Rev Oncol Hematol. 2020;152:102991.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献